See also this year's filing and all EDGAR filings for this company.
PDF Report 0001503518_2015_21st_Century_Oncology_Holdings_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.004209986069359924, 'aggregate_val': 1369642000, 'exp_sum': 1363900000, 'exp_to_value': {'LaborExpense': 545025000, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 135257000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 61735000, 'DepreciationDepletionAndAmortization': 86701000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 535182000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - Condenses Consolidated Statements Of Operations And Comprehensive Loss (Alternative)': 6, '00200 - Statement - Consolidated Statements Of Operations And Comprehensive Loss': 30}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001503518, 21st Century Oncology Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 551,276,000 |
| 1 | AssetsNonCurrent | 37,176,000 |
| 2 | AssetsCurrent | 264,963,000 |
| 3 | PropertyPlantAndEquipment | 270,757,000 |
| 4 | remainder_Assets | 22,552,000 |
| 5 | LongTermLiabilities | 991,850,000 |
| 6 | LiabilitiesCurrent | 188,828,000 |
| 7 | remainder_Liabilities | 43,933,000 |
| 8 | LaborExpense | 545,025,000 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 135,257,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 61,735,000 |
| 13 | DepreciationDepletionAndAmortization | 86,701,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 540,924,000 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | 1,026,422,000 |
| 19 | remainder_ComprehensiveNetIncome | -18,327,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,146,724,000 |
| 1 | Liabilities | 1,224,611,000 |
| 2 | Expenses | 1,369,642,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -77,887,000 |
| 5 | NetIncome | -343,220,000 |
| 6 | ComprehensiveNetIncome | -361,547,000 |
| 7 | BaseVar | 2,392,863,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.400 |
| 9 | EconomicCapitalRatio | 0.846 |
Edgar->Model Mapping
Feature Distribution
Change over Time
